Sarfaraz K. Niazi

What’s the Deal with Biosimilars? Biosimilars are gaining momentum as new protein therapeutic candidates that can help fill a vital need in the healthcare industry. These biological drugs are produced by recombinant DNA technology, allowing for large-scale production and an overall reduction in time and costs of development. Part of a two-volume set that covers varying aspects of biosimilars, Biosimilars...